Value Aligned Research Advisors’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$420M Buy
1,491,494
+341,666
+30% +$99.1M 2.03% 12
2025
Q4
$340M Sell
1,149,828
-209,883
-15% -$63.3M 3.42% 10
2025
Q3
$335M Buy
1,359,711
+168,390
+14% +$33.9M 4.09% 7
2025
Q2
$186M Buy
1,191,321
+694,868
+140% +$73.9M 3.93% 12
2025
Q1
$39.1M Buy
496,453
+413,777
+500% +$43.9M 2.85% 10
2024
Q4
$7.63M Buy
82,676
+5,466
+7% +$428K 2.09% 14
2024
Q3
$3.95M Buy
77,210
+7,854
+11% +$406K 1.03% 13
2024
Q2
$3.98M Buy
+69,356
New +$3.5M 0.87% 15

Other funds holding CLS

Value Aligned Research Advisors's CLS Position: Q1 2026 in Review

Value Aligned Research Advisors increased its Celestica (CLS) stake by 30% in Q1 2026, buying an estimated $99.1M and bringing the position to 1,491,494 shares worth $420M. The position accounts for 2.03% of the portfolio, ranked #12.

Value Aligned Research Advisors first reported a position in CLS in Q2 2024 and has held it in 8 quarters since. 773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • Value Aligned Research Advisors held 1,491,494 shares of Celestica worth $420M as of Q1 2026.
  • Value Aligned Research Advisors bought 341,666 Celestica shares in Q1 2026, an estimated $99.1M.
  • Celestica made up 2.03% of Value Aligned Research Advisors's portfolio in Q1 2026, its #12 holding.
  • Value Aligned Research Advisors first reported a position in Celestica in Q2 2024 and has held it in 8 quarters since.
  • 773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Value Aligned Research Advisors's 13F filing for Q1 2026, filed 18 May 2026.